|
|
|
Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 37-43
|
|
Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
PACLITAXEL;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
BREAST CANCER;
BREAST METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CROSS RESISTANCE;
DOSE RESPONSE;
DRUG EFFICACY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CYCLOPHOSPHAMIDE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
MIDDLE AGED;
NEUTROPENIA;
PACLITAXEL;
REMISSION INDUCTION;
|
|
EID: 0029873267
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
